Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Wait for a Pullback Before Pulling the Nvidia Stock Trigger

By Larry Ramer, InvestorPlace Contributor

With NVDA stock likely to take some punches relatively soon, investors should avoid the shares for now. But be prepared to buy it on dips.

Cassava Sciences Stock Is a Buy on the Strength of a Promising Alzheimer’s Drug

By Larry Ramer, InvestorPlace Contributor

Skeptics are wrong about Cassava's Alzheimer's drug, as the drug's data is superb. Long-term investors should buy SAVA stock.

Palantir Stock Looks More Overvalued by the Day as Costs Keep Rising

By Larry Ramer, InvestorPlace Contributor

PLTR stock has a huge valuation that does not seem to be justified by the company's financial results or technology.

Paysafe Stock Is Probably the Best of the Upstart Fintechs Out There

By Larry Ramer, InvestorPlace Contributor

PSFE stock is the type of underestimated, little-noticed, high-quality name that usually handsomely reward long-term investors.

Tilray Stock Is Probably Overvalued At This Price

By Larry Ramer, InvestorPlace Contributor

TLRY stock currently reflects unrealistic assumptions about its growth and about the chances of legalization in the United States.

Load More